Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study

Objectives:. We aimed to describe the characteristics and outcome in children with severe Mycoplasma pneumoniae pneumonia in a Chinese PICU. Design:. A retrospective observational study from 2017 to 2019. Setting:. A 36-bed university tertiary PICU at Shanghai Children’s Hospital. Patients:. Patient...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yiping Zhou, MD, Yijun Shan, MD, Yun Cui, MD, Jingyi Shi, MD, PhD, Fei Wang, MD, Huijie Miao, MD, Chunxia Wang, PhD, Yucai Zhang, PhD, Hari Krishnan Kanthimathinathan, Roddy O’Donnell, Michelle Jardine, Jo Lumsden, Jeremy Tong, Anand Wagh, Pascale du Pre, Andrew Nyman, Bogdana Zoica, Rachel Neal, Rebecca Mitting, Konstantinos Dimitraides, Claire Jennings, Karen Coxon, Charlotte Goedvolk, James Weitz, Jade Bryant, Jillian MacFadzean, Alastair Turner
Formato: article
Lenguaje:EN
Publicado: Wolters Kluwer 2021
Materias:
Acceso en línea:https://doaj.org/article/e34cb04a26394359ab9f9fce7b667305
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e34cb04a26394359ab9f9fce7b667305
record_format dspace
spelling oai:doaj.org-article:e34cb04a26394359ab9f9fce7b6673052021-11-25T07:54:10ZCharacteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study2639-802810.1097/CCE.0000000000000366https://doaj.org/article/e34cb04a26394359ab9f9fce7b6673052021-03-01T00:00:00Zhttp://journals.lww.com/10.1097/CCE.0000000000000366https://doaj.org/toc/2639-8028Objectives:. We aimed to describe the characteristics and outcome in children with severe Mycoplasma pneumoniae pneumonia in a Chinese PICU. Design:. A retrospective observational study from 2017 to 2019. Setting:. A 36-bed university tertiary PICU at Shanghai Children’s Hospital. Patients:. Patients admitted to a tertiary PICU 29 days to 18 years old screened for laboratory-confirmed severe M. pneumoniae pneumonia. Interventions:. None. Measurements and Main Results:. Descriptive analysis of baseline characteristics for patients included hospital mortality, organ dysfunctions, use of mechanical ventilation, continuous renal replacement therapy, and/or extracorporeal membrane oxygenation. A total of 817 children with severe pneumonia were admitted to PICU, and 203 of 817 cases (24.8%) with severe M. pneumoniae pneumonia were included in this study. The median age was 41 months (interquartile range, 20–67 mo), of which 77.3% (157/203) were younger than 6 years old. Among 163 patients with the test for macrolide resistance, 90.2% cases (147/163) were macrolide-resistant M. pneumoniae. Severe M. pneumoniae pneumonia-associated organ dysfunction included acute respiratory failure (203 cases, 100%), followed by cardiovascular disorder (79/203, 38.9%), gastrointestinal dysfunction (24/203, 11.8%). The main complications were pleural effusion (79/203, 38.9%), capillary leak syndrome (58/203, 28.6%), and plastic bronchitis (20/203, 9.9%). All patients needed respiratory support, including 64.5% patients (131/203) who received mechanical ventilation and 35.5% patients (72/203) who received high-flow nasal oxygen. Twenty-five patients (12.3%) treated with continuous renal replacement therapy and nine cases (4.4%) received extracorporeal membrane oxygenation. The case fatality rate was 3.9% (8/203). Furthermore, cardiovascular dysfunction, liver injury, or multiple organ dysfunction syndrome were associated with longer mechanical ventilation duration, delayed PICU discharge, and high hospital mortality. Coinfection was a risk factor of delayed PICU discharge. Conclusions:. Children with severe M. pneumoniae pneumonia mainly occur under the age of 6 years, showing a high proportion of extrapulmonary organ dysfunction and macrolide resistances. Extrapulmonary organ dysfunction and coinfection are associated with worse outcomes. The overall mortality is relatively low after treated with appreciate antibiotics, respiratory support, and extracorporeal life support.Yiping Zhou, MDYijun Shan, MDYun Cui, MDJingyi Shi, MD, PhDFei Wang, MDHuijie Miao, MDChunxia Wang, PhDYucai Zhang, PhDHari Krishnan KanthimathinathanRoddy O’DonnellMichelle JardineJo LumsdenJeremy TongAnand WaghPascale du PreAndrew NymanBogdana ZoicaRachel NealRebecca MittingKonstantinos DimitraidesClaire JenningsKaren CoxonCharlotte GoedvolkJames WeitzJade BryantJillian MacFadzeanAlastair TurnerWolters KluwerarticleMedical emergencies. Critical care. Intensive care. First aidRC86-88.9ENCritical Care Explorations, Vol 3, Iss 3, p e0366 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
spellingShingle Medical emergencies. Critical care. Intensive care. First aid
RC86-88.9
Yiping Zhou, MD
Yijun Shan, MD
Yun Cui, MD
Jingyi Shi, MD, PhD
Fei Wang, MD
Huijie Miao, MD
Chunxia Wang, PhD
Yucai Zhang, PhD
Hari Krishnan Kanthimathinathan
Roddy O’Donnell
Michelle Jardine
Jo Lumsden
Jeremy Tong
Anand Wagh
Pascale du Pre
Andrew Nyman
Bogdana Zoica
Rachel Neal
Rebecca Mitting
Konstantinos Dimitraides
Claire Jennings
Karen Coxon
Charlotte Goedvolk
James Weitz
Jade Bryant
Jillian MacFadzean
Alastair Turner
Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study
description Objectives:. We aimed to describe the characteristics and outcome in children with severe Mycoplasma pneumoniae pneumonia in a Chinese PICU. Design:. A retrospective observational study from 2017 to 2019. Setting:. A 36-bed university tertiary PICU at Shanghai Children’s Hospital. Patients:. Patients admitted to a tertiary PICU 29 days to 18 years old screened for laboratory-confirmed severe M. pneumoniae pneumonia. Interventions:. None. Measurements and Main Results:. Descriptive analysis of baseline characteristics for patients included hospital mortality, organ dysfunctions, use of mechanical ventilation, continuous renal replacement therapy, and/or extracorporeal membrane oxygenation. A total of 817 children with severe pneumonia were admitted to PICU, and 203 of 817 cases (24.8%) with severe M. pneumoniae pneumonia were included in this study. The median age was 41 months (interquartile range, 20–67 mo), of which 77.3% (157/203) were younger than 6 years old. Among 163 patients with the test for macrolide resistance, 90.2% cases (147/163) were macrolide-resistant M. pneumoniae. Severe M. pneumoniae pneumonia-associated organ dysfunction included acute respiratory failure (203 cases, 100%), followed by cardiovascular disorder (79/203, 38.9%), gastrointestinal dysfunction (24/203, 11.8%). The main complications were pleural effusion (79/203, 38.9%), capillary leak syndrome (58/203, 28.6%), and plastic bronchitis (20/203, 9.9%). All patients needed respiratory support, including 64.5% patients (131/203) who received mechanical ventilation and 35.5% patients (72/203) who received high-flow nasal oxygen. Twenty-five patients (12.3%) treated with continuous renal replacement therapy and nine cases (4.4%) received extracorporeal membrane oxygenation. The case fatality rate was 3.9% (8/203). Furthermore, cardiovascular dysfunction, liver injury, or multiple organ dysfunction syndrome were associated with longer mechanical ventilation duration, delayed PICU discharge, and high hospital mortality. Coinfection was a risk factor of delayed PICU discharge. Conclusions:. Children with severe M. pneumoniae pneumonia mainly occur under the age of 6 years, showing a high proportion of extrapulmonary organ dysfunction and macrolide resistances. Extrapulmonary organ dysfunction and coinfection are associated with worse outcomes. The overall mortality is relatively low after treated with appreciate antibiotics, respiratory support, and extracorporeal life support.
format article
author Yiping Zhou, MD
Yijun Shan, MD
Yun Cui, MD
Jingyi Shi, MD, PhD
Fei Wang, MD
Huijie Miao, MD
Chunxia Wang, PhD
Yucai Zhang, PhD
Hari Krishnan Kanthimathinathan
Roddy O’Donnell
Michelle Jardine
Jo Lumsden
Jeremy Tong
Anand Wagh
Pascale du Pre
Andrew Nyman
Bogdana Zoica
Rachel Neal
Rebecca Mitting
Konstantinos Dimitraides
Claire Jennings
Karen Coxon
Charlotte Goedvolk
James Weitz
Jade Bryant
Jillian MacFadzean
Alastair Turner
author_facet Yiping Zhou, MD
Yijun Shan, MD
Yun Cui, MD
Jingyi Shi, MD, PhD
Fei Wang, MD
Huijie Miao, MD
Chunxia Wang, PhD
Yucai Zhang, PhD
Hari Krishnan Kanthimathinathan
Roddy O’Donnell
Michelle Jardine
Jo Lumsden
Jeremy Tong
Anand Wagh
Pascale du Pre
Andrew Nyman
Bogdana Zoica
Rachel Neal
Rebecca Mitting
Konstantinos Dimitraides
Claire Jennings
Karen Coxon
Charlotte Goedvolk
James Weitz
Jade Bryant
Jillian MacFadzean
Alastair Turner
author_sort Yiping Zhou, MD
title Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study
title_short Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study
title_full Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study
title_fullStr Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study
title_full_unstemmed Characteristics and Outcome of Severe Mycoplasma pneumoniae Pneumonia Admitted to PICU in Shanghai: A Retrospective Cohort Study
title_sort characteristics and outcome of severe mycoplasma pneumoniae pneumonia admitted to picu in shanghai: a retrospective cohort study
publisher Wolters Kluwer
publishDate 2021
url https://doaj.org/article/e34cb04a26394359ab9f9fce7b667305
work_keys_str_mv AT yipingzhoumd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT yijunshanmd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT yuncuimd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT jingyishimdphd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT feiwangmd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT huijiemiaomd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT chunxiawangphd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT yucaizhangphd characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT harikrishnankanthimathinathan characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT roddyodonnell characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT michellejardine characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT jolumsden characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT jeremytong characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT anandwagh characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT pascaledupre characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT andrewnyman characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT bogdanazoica characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT rachelneal characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT rebeccamitting characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT konstantinosdimitraides characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT clairejennings characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT karencoxon characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT charlottegoedvolk characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT jamesweitz characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT jadebryant characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT jillianmacfadzean characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
AT alastairturner characteristicsandoutcomeofseveremycoplasmapneumoniaepneumoniaadmittedtopicuinshanghaiaretrospectivecohortstudy
_version_ 1718413652784054272